M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Former Big 12 Rivals Go Head To Head In Exclusive Onstage Interview
Johnson, at the fifth annual San Antonio A Conversation With a Living Legend®. The event will take place Monday, Nov. 10 at the Marriott Rivercenter Grand Ballroom (third floor), 101 Bowie St. The luncheon has raised almost half a million dollars for The University of Texas MD Anderson Cancer Center's Moon Shots Program, a comprehensive effort to accelerate the fight against cancer.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - November 5, 2014 Category: Cancer & Oncology Source Type: news

Proton Therapy Shown to be Less Costly than Some Alternative Radiotherapy Techniques for Early Stage Breast Cancer
In terms of duration of treatment and cost, patients with early stage breast cancer may benefit from accelerated partial breast irradiation (APBI) with proton therapy versus whole breast irradiation (WBI), according to new research from The University of Texas MD Anderson Proton Therapy Center.   (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 31, 2014 Category: Cancer & Oncology Source Type: news

In year two, MD Anderson Moon Shots Program begins to spin off innovation
Improved surgical outcomes for ovarian cancer, expanded potential impact for new drugs, and a novel family outreach program to head off cancers fueled by known genetic risk mutations are among the early innovations of The University of Texas MD Anderson Cancer Center's Moon Shots Program. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 30, 2014 Category: Cancer & Oncology Source Type: news

Oxygen-deprived RNA molecules lead to tumor progression
New research at  MD Anderson Cancer Center has unearthed a previously unknown phenomenon: Key regulatory molecules are decreased when deprived of oxygen which leads to increased cancer progression in vitro and in vivo. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 29, 2014 Category: Cancer & Oncology Source Type: news

Cancer exosomes are 'micro factories' that aid in tumor growth
Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 23, 2014 Category: Cancer & Oncology Source Type: news

YEATS Protein Potential Therapeutic Target for Cancer
Federal Express® and UPS® are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 23, 2014 Category: Cancer & Oncology Source Type: news

Two faculty elected to Institute of Medicine
"Two leaders at The University of Texas MD Anderson Cancer Center have been elected to the Institute of Medicine (IOM) of the National Academies in recognition of their contributions to medical science and health care. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 20, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson study first to compare treatments, survival benefits for early-stage lung cancer
Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 15, 2014 Category: Cancer & Oncology Source Type: news

San Antonio A Conversation With a Living Legend® slates UT's Mack Brown, A&M's R.C. Slocum
Two of the greatest legends in Texas football coaching history, Mack Brown and R.C. Slocum, will be honored at the fifth annual A Conversation With a Living Legend® in San Antonio, 11:30 a.m. to 1:30 p.m. Nov. 10 at the Marriott Rivercenter. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 6, 2014 Category: Cancer & Oncology Source Type: news

Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration
Bristol-Myers Squibb Company (NYSE: BMY) and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 6, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson teams up to implement tobacco-free policies in mental health clinics
MD Anderson is extending its cancer prevention efforts by teaming up with anti-tobacco programs run by the University of Houston and Austin Travis County Integral Care (ATCIC). The partnership joins researchers focused on educating mental health providers and tobacco users to eliminate a dangerous addiction. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 3, 2014 Category: Cancer & Oncology Source Type: news

Khalifa Institute for Personalized Cancer Therapy announces fellowship program
The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy at The University of Texas MD Anderson Cancer Center has launched a fellowship program to advance the discovery and delivery of effective and accessible personalized cancer treatments. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 3, 2014 Category: Cancer & Oncology Source Type: news

Researchers discover gene that can predict aggressive prostate cancer at diagnosis
Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 2, 2014 Category: Cancer & Oncology Source Type: news

Study Indicates Possible New Way to Treat Endometrial, Colon Cancers
A study led by Gordon Mills, M.D., Ph.D., professor and chair of Systems Biology at MD Anderson Cancer Center with Lydia Cheung, Ph.D. as the first author, points to cellular mutations in the gene PIK3R1 which activate ERK and JNK, thus allowing tumor growth. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 2, 2014 Category: Cancer & Oncology Source Type: news

ExxonMobil commits $10 million to MD Anderson's cancer prevention and control initiative
ExxonMobil today announced a $10 million grant to The University of Texas MD Anderson Cancer Center's Moon Shots Program, an unprecedented, comprehensive initiative to significantly reduce deaths from cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 2, 2014 Category: Cancer & Oncology Source Type: news